The first malaria vaccine to be recommended and prequalified by WHO is moving into broader implementation, while a leading malaria vaccine candidate is in Phase 3 evaluation. Other immunization approaches, including monoclonal antibodies and mRNA vaccines, are in development. This webinar will
explore key challenges to vaccine development and access— financial, scientific, and delivery—with perspectives offered by experts in their respective fields.

During this webinar, you’ll learn more about:
▪ The malaria vaccines and biologics landscape: Current status and the next 5 years
▪ Financial and economic challenges in malaria product development, introduction and access
▪ The implementation challenge of delivering malaria vaccines in areas with seasonal malaria

Registration and speaker information below.